Preimplantation Genetic Testing Market to Reach $1.08 Billion

The global market for preimplantation genetic testing is projected to surge, reaching an estimated $1,081.9 million by 2033. This significant growth is attributed to increasing adoption of in vitro fertilization (IVF) procedures and continuous advancements in genetic testing technologies. The market, valued at approximately $598.4 million in 2026, is experiencing a steady upward trajectory. These developments highlight the growing importance of genetic screening in reproductive medicine and fertility treatments worldwide.